adMare has helped build 36 companies, of which 25 are still active. These companies have attracted $2.4 billion of risk capital, have a combined value of $5.7 billion, and have created around 1,000 jobs in Canada.
Evolved Therapeutics is focused on establishing innovative antibody discovery platforms to enable the discovery of first- and best-in-class therapeutics.